Fred Alger Management »

Dianthus Therapeutics shares owned by Fred Alger Management

Quarter-by-quarter ownership of Dianthus Therapeutics (DNTH) shares owned by Fred Alger Management from 13F filings

Historical chart of Fred Alger Management investment in Dianthus Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Dianthus Therapeutics held by Fred Alger Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Dianthus Therapeutics by Fred Alger Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $425k 41k 10.40

More positions owned by Fred Alger Management

Microsoft Corp Common (MSFT)
Amazon Common (AMZN)
Apple Common (AAPL)
Nvidia Corp. Common (NVDA)
Meta Platforms Inc Class A Common (META)
Alphabet Inc Cl C Common (GOOG)
Natera Common (NTRA)
Visa Inc Class A Shares Common (V)
Mercadolibre Common (MELI)
Transdigm Group Common (TDG)
Adobe Common (ADBE)
Marvell Technology Group Common (MRVL)
Gfl Environmental Common (GFL)
Pinterest Inc Class A Common (PINS)
Advanced Micro Devices Common (AMD)

View all positions for Fred Alger Management

Top funds holding Dianthus Therapeutics

Fairmount Funds Management
5AM Venture Management
Avidity Partners Management
VR Adviser
Octagon Capital Advisors
Tang Capital Management
Nantahala Capital Management
Alphabet
Susquehanna International
Atlas Venture Life Science Advisors
Vanguard Group
Fred Alger Management
Pnc Financial Services
Millennium Management
Laurion Capital Management

View all funds holding Dianthus Therapeutics